Literature DB >> 3730980

Cryptosporidium infections: a laboratory survey.

K A Elsser, M Moricz, E M Proctor.   

Abstract

Between Oct. 1, 1983, and June 30, 1985, Cryptosporidium oocysts were identified in stool specimens from 74 patients who presented with gastrointestinal symptoms to their physicians. Questionnaires prepared to determine travel history, symptoms, duration of illness and epidemiologic characteristics of the infection were completed for 67 (90%) of the patients by their physicians; the information on the other 7 patients was obtained from the requisitions accompanying the specimens. Of the 67, 35 (52%) had recently been to Mexico. The infection was likely transmitted through contaminated water, food and, possibly, milk. The infections in patients who had not travelled were thought to be due to contact with infected pets or farm animals or with infected children attending daycare centres. Diarrhea, vomiting, fever and nausea usually lasted for 1 to 2 weeks, except in those with immune deficiency, in whom the symptoms persisted for up to 6 months. The condition was diagnosed by identification of oocysts in stool specimens that underwent formalin-ether sedimentation and modified cold Kinyoun staining.

Entities:  

Mesh:

Year:  1986        PMID: 3730980      PMCID: PMC1491164     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  10 in total

1.  Fluorescence microscopy of tubercle bacilli stained with auramine and rhodamine.

Authors:  J P TRUANT; W A BRETT; W THOMAS
Journal:  Henry Ford Hosp Med Bull       Date:  1962-06

2.  Cryptosporidiosis in northeastern Brazil: association with sporadic diarrhea.

Authors:  C S Weikel; L I Johnston; M A De Sousa; R L Guerrant
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

3.  Cryptosporidium: a frequent finding in patients with gastrointestinal symptoms.

Authors:  L Jokipii; S Pohjola; A M Jokipii
Journal:  Lancet       Date:  1983-08-13       Impact factor: 79.321

4.  Cryptosporidium: evidence for a single-species genus.

Authors:  S Tzipori; K W Angus; I Campbell; E W Gray
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

Review 5.  Cryptosporidiosis: clinical, epidemiologic, and parasitologic review.

Authors:  T R Navin; D D Juranek
Journal:  Rev Infect Dis       Date:  1984 May-Jun

6.  Cryptosporidiosis in an urban community.

Authors:  D A Hunt; R Shannon; S R Palmer; A E Jephcott
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-29

7.  Cryptosporidiosis in children from some highland Costa Rican rural and urban areas.

Authors:  L Mata; H Bolaños; D Pizarro; M Vives
Journal:  Am J Trop Med Hyg       Date:  1984-01       Impact factor: 2.345

8.  Human cryptosporidiosis in immunocompetent and immunodeficient persons. Studies of an outbreak and experimental transmission.

Authors:  W L Current; N C Reese; J V Ernst; W S Bailey; M B Heyman; W M Weinstein
Journal:  N Engl J Med       Date:  1983-05-26       Impact factor: 91.245

9.  Cryptosporidiosis in immunocompetent patients.

Authors:  J S Wolfson; J M Richter; M A Waldron; D J Weber; D M McCarthy; C C Hopkins
Journal:  N Engl J Med       Date:  1985-05-16       Impact factor: 91.245

Review 10.  Cryptosporidiosis in man, domestic animals and birds: a review.

Authors:  K W Angus
Journal:  J R Soc Med       Date:  1983-01       Impact factor: 18.000

  10 in total
  4 in total

Review 1.  Contemporary issues: diseases with a food vector.

Authors:  D L Archer; F E Young
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

Review 2.  An overview of methods/techniques for the detection of Cryptosporidium in food samples.

Authors:  Shahira A Ahmed; Panagiotis Karanis
Journal:  Parasitol Res       Date:  2018-01-19       Impact factor: 2.289

Review 3.  Cryptosporidiosis.

Authors:  W L Current; L S Garcia
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

4.  Is drinking water a risk factor for endemic cryptosporidiosis? A case-control study in the immunocompetent general population of the San Francisco Bay Area.

Authors:  Asheena Khalakdina; Duc J Vugia; Joelle Nadle; Gretchen A Rothrock; John M Colford
Journal:  BMC Public Health       Date:  2003-03-07       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.